To the best of our knowledge, the current study is the first to demonstrate a protective role for caspase-1 inhibition in preventing neonatal hyperoxia-induced aortic stiffness, cardiac inflammation, and cardiac fibrosis, associated with decreased IL-1β and GSDMD levels in both the aorta and heart. The gene discussed is CASP1; the disease is inflammation.